Criteria adopted in different models of public healthcare systems for the evaluation of reimbursement recommendations of orphan drugs: a scoping review.

• Κύριοι συγγραφείς: Arturo Felippini (Συγγραφέας), Luiza Vasconcelos Biglia (Συγγραφέας), Tácio Mendonça Lima (Συγγραφέας), Patricia Melo Aguiar (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia, 2023-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Introdução: Access to drugs for rare diseases constitutes a challenge to healthcare systems, especially those with public funding. The difficulty of conducting robust clinical trials limits the quality of evidence and elevates the cost of development, later translated into the drug's prices. Th...